SlideShare a Scribd company logo
1 of 10
Download to read offline
Anti-Counterfeiting Pharma 2015
11th-12th March 2015
Marriott Regents Park, London, UK
Roadmap
and patient safety
to brand protection
Prominent Speakers:-
üSophie Molle ,IPM Private Sector – Senior Manager, World Customs Organization
üRoger Pallavicini, Sales Director Europe, Jura JSP GmbH
üAndrew Love, VP Capability Development Be4ward Ltd
üEdmond D'arvieu, Chief Security Officer, Sanofi
üEric Noehrenberg, Regional Market Access and Policy Lead, Shire Pharmaceuticals
üDammika Peiris, Pharmacovigilance Manager and Head of Chugai Pharma Marketing
Pharmacovigilance Office, Chugai Pharma UK Ltd
üSumit Munjal, Medical Director Lead, Global Medical Safety, Takeda Pharmaceuticals
üAdesina Iluyemi, Executive Board member, NEPAD Council
üMartin FitzGerald, Deputy Director General, GIRP
üJanice Kite, Traceability Director Healthcare, GS1 Global Office
üStephen Wilkins, Secretary, Child Safe Packaging Group
üPaul Abbott, Associate, Arnold & Porter (UK) LLP
üStephen Truick, Internet Infrastructure Manager, MHRA
üMark Davison, CEO, Blue Sphere Health Ltd
üStephen McIndoe, Vice President, Be4ward Ltd
üJean-Luc Lasne, International Business Development & Alliance
Director, Adents Pharma
Media Partner
Premium Sponsor
Exhibitor
Associate Sponsor
Floor Plan
13 14 15 16
12 11 10 9
1
2
Refreshment Station
Conference Hall
4
3
Registration
6
7
8
RefreshmentStation
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
5
Identify the current market trends in anti-counterfeiting, brand?
protection and security packaging
Gain Sanofi's perspective on key strategies for combating?
anti-counterfeiting
Overcome the main issues of online pharmaceutical crime?
by learning from the presentation by MHRA.
Understand the parallel trade, counterfeit products and?
public health issues from Shire Pharmaceuticals.
Hear thought provoking case study about preventing poisoning?
through mobile technology by NEPAD Council.
Discover latest solutions of future proofing a secure supply chain that will improve?
your business model with The European Association of Pharmaceutical Full-line
Wholesalers.
Examine the recent EU&US anti-counterfeiting legislation with Arnold & Porter (UK)?
LLP that will shape your future decisions.
Learn how to enable regulatory compliance, supply chain security and patient safety?
with GS1.
Develop your serialisation strategy by learning from the experts from Blue Sphere?
Health Ltd and Be4ward Ltd.
Take part in the panel and roundtable discussions to interact, discuss and debate the?
most crucial topics of anti-counterfeiting and brand protection in the industry.
Why Attend??
Anti-Counterfeiting experts?
R&D?
Supply Chain and Track & Trace?
Serialisation?
Packaging Technologists?
Regulatory Affairs, Intellectual Property and Trademarks?
Innovation, Design and Development?
Sales & Marketing?
Brand Protection?
Who will be attending?
Day One: 11th March 2015
10:10 GS1 Standards: A tool for fighting counterfeiting?
Ø
ØThe latest in GS1 developments
ØEnabling regulatory compliance, supply chain security and patient safety
Daily interaction is natural and unnoticed
Andrew Love, VP Capability Development, Be4ward Ltd
09:00 Chairman's opening remarks
09:10 Market trends: Anti-counterfeiting and Brand Protection
ØMarket trends in anti-counterfeiting, brand protection and security packaging
ØTrends in pharmaceutical packaging
ØTechnologies and innovations
ØOutlook for pharma security packaging
Senior Representative, Smithers Pira
ØLegal framework
ØCounterfeit characteristics
ØCounterfeit trends and opportunities: supply chain, diversion, parallel trade and product thefts
ØAnti-counterfeit strategy: Two pillars
09:40 Key strategies for combating anti-counterfeiting - a pharma industry engagement
Edmond D'arvieu, Chief Security Officer, Sanofi
Janice Kite, Traceability Director Healthcare, GS1 Global Office
11:10 How to make your serialization project a success ?
Mark Davison, CEO, Blue Sphere Health Ltd
11:30 Linking corporate strategy, brand protection and patient safety
ØSerialisation and authentication as business critical initiatives
ØProcess issues: what to look for
ØAre you complying or competing? Achieving the elusive upside
08:30 Registration & refreshments
10:40 Coffee break & Speed Networking
ØChoosing a relevant equipment
ØPay attention to data exchange
ØThe extra challenge of CMOs
Jean-Luc Lasne, International Business Development & Alliance Director, Adents Pharma
14:20 Panel Discussion: Is the pharmaceutical industry doing enough to tackle counterfeit pharma products?
ØChallenges in the industry
ØSolutions that matter
ØPublic and Private Sectors acting together against drug counterfeit
Moderator: Andrew Love, VP Capability Development, Be4ward Ltd
Panelists:
?Mark Davison, CEO, Blue Sphere Health Ltd
?Adesina Iluyemi, Executive Board member, NEPAD Council
?Edmond D'arvieu, Chief Security Officer, Sanofi
?Senior Representative, Aegate
Roger Pallavicini, Sales Director Europe, Jura JSP GmbH
14:00 Add authentication to your identification system
12:20 Developing your Serialisation Strategy
ØWhat are the capabilities that need to be implemented in a company to meet the needs of serialisation?
ØHow do you ensure that the requirements for serialisation are thoroughly understood and
capabilities effectively designed?
ØHow do you ensure effective engagement across your extended supply chain?
ØHow do you go about developing your serialisation strategy?
Stephen McIndoe, Vice President Consulting, Be4ward Ltd
15:40 Panel Discussion: Is the pharmaceutical industry doing enough to tackle counterfeit pharma products?
12:50 Networking Lunch
ØShare your views and provide an overview of your product/services to the audience
12:00 Sponsor Spotlight Session
15:20 Networking Coffee
Ø
ØSolutions that matter
ØPublic and Private Sectors acting together against drug counterfeit
Moderator: Andrew Love, VP Capability Development,Be4ward Ltd
Panelists:
• Stephen Wilkins, Secretary, Child Safe Packaging Group
• Sumit Munjal,Medical Director Lead,Global Medical Safety ,Takeda Pharmaceuticals
• Dammika Peiris ,Pharmacovigilance Manager and Head of Chug ai Pharma Marketing
Pharmacovigilance Office, Chugai Pharma UK Ltd
Challenges in the industry
17:10 Chairman's closing remarks
17:20 Networking drinks reception
ØShare your views and provide an overview of your product/services to the audience
16:50 Sponsor Spotlight Session
16:20 Online Pharmaceutical Crime
ØThe main issues - why is this still a problem
ØThe current picture - it's not all Doom and Gloom
ØThe future - when is a Door not a Door?
Stephen Truick, Internet Infrastructure Manager, MHRA
Day Two : 12th March 2015
Andrew Love, VP Capability Development, Be4ward Ltd
09:00 Chairman's opening remarks
09:10 Parallel trade and counterfeit products
ØParallel trade, counterfeiting and public health
ØThe extent of parallel trade and exploitation of parallel trade by drug counterfeiters
ØImpact of EU Falsified Medicines Directive on parallel trade and counterfeiting
ØImportance of cross-sectoral collaboration (including parallel traders) to fight counterfeiting
Eric Noehrenberg, Regional Market Access and Policy Lead, Shire Pharmaceuticals
ØDrug counterfeiting a public health problem in Africa
ØAn international view of drug counterfeiting in Africa
ØCases studies of how mobile technology us empowering consumers and regulators
10:00 Preventing poisoning- mobile technology to the rescue
Adesina Iluyemi, Executive Board member, NEPAD Council
Senior Representative, Yellow BP
10:30 Presentation to be announced
Martin FitzGerald, Deputy Director General,The European Association of Pharmaceutical Full-line
Wholesalers (GIRP)
11:20 Future proofing a secure supply chain
ØAddressing the challenges of supply chain security through medicines verification systems
ØStrategies for improving medicines supply
ØInnovative partnerships between wholesalers and manufacturers in the area of services
08:30 Refreshments
10:50 Networking Coffee
ØShare your views and provide an overview of your product/services to the audience
09:40 Sponsor Spotlight Session
15:50 Round table discussion
Round table discussion with today's speakers and audience
14:00 EU & US anti-counterfeiting legislation
ØBorder measures in the EU: the legislative framework
ØThe international situation: where are we with ACTA / future regulation of IP enforcement
globally?
ØPractical measures for preventing import of counterfeit pharmaceuticals
16:30 Chair summary of the day and close of conference
Paul Abbott, Associate, Arnold & Porter (UK) LLP
11:50 Presentation to be announced
Stephen Wilkins, Secretary, Child Safe Packaging Group
Sophie Molle, IPM Private Sector – Senior Manager, World Customs Organization
14:30 IPM- A WCO global initiative to fight against counterfeiting
12:40 Networking Lunch
15:20 Raising public awareness of the dangers of counterfeit medicines
15:00 Networking Coffee
Share your views and provide an overview of your product/services to the audience
12:20 Sponsor Spotlight Session
Delegate Pricing Information
Book by
25 Dec2014 30 Jan 2015 30 Jan 2015
(Save upto ) (Save upto ) Standard Price
1 Delegate £550+ Vat £750+ Vat £950 + Vat
3 Delegates £1100+ Vat £1500 + Vat £1900+ Vat
Book by Book after
£800 £400
Commercial Opportunities:-
Anti-Counterfeiting Pharma 2015
offers various opportunities for you
to promote and showcase your
organisation to the attendees.
If you are interested in learning
more about how we can work
together please contact
Sarika Sareen at
sarika@recunnect.com
Terms & Conditions:
Payment Terms
Recunnect Ltd. requires full payment of the amount to be made before the conference. We may refuse entry to a delegateor sponsor who have not paid in full.
Cancellation or Substitution Policy
Once registered, these places are not transferable without the agreement of Recunnect Ltd. for which reasonable priornotice must be given.For any cancellations received
in writing not less than eight (8) days prior to the event, we will provide you with a 90%credit to be used at another Recunnect Ltd. event which must occur within one year
from the date of issuance of suchcredit. An administration fee of 10% of the registration fee will be retained by Recunnect Ltd. for all permittedcancellations. No credit will
be issued for any cancellations occurring within seven (7) days (inclusive) of the event.
Indemnity
Recunnect Ltd. reserves the right to make alterations to the event / executive briefing content, timing, speakers orprogram and venues. Where major or significant changes
occur shortly before the conference date, Recunnect Ltd. willendeavor to take reasonable steps to notify the customers using the contact details supplied.The event may be
postponed or cancelled due to unforeseen events beyond the control of Recunnect Ltd. In the eventthat Recunnect Ltd. cancels or postpones an event for any reason, the
customer will receive a refund of the of theregistration fee paid. The refund will be made within 30 days from the date of cancellation of the conference.
Fee
The conference fee includes lunch, refreshments and conference papers provided on the day. This fee does not includetravel, hotel accommodation, transfers or insurance,
(which we strongly recommend you obtain).
Contact
Our preferred method of communication is by email and phone. Please ensure that you complete the registration form infull so that we can contact you.
By signing up for this conference you agree to abide by our terms and conditions. Please refer to our website for our fullterms and conditions.
http://www.recunnect.com/terms-and-conditions.html
RegistrationChecklist:-
üHave you checked if any other colleagues are
attending?
üBooking early enough for maximum
advantage?
üAreyouavailingour3forthepriceof2offer?
üUseyouraccountmanagercodetoavail
£50discount.
Ways to Book:-
ü
üCall +44 (0) 2071129183
üEmail: info@recunnect.com
http://www.recunnect.com/p-anti-registration.html

More Related Content

Similar to Anti-Counterfeiting Pharma 2015

Pharma Security World 2018 Anti-counterfeiting, Serialization & Brand Safety ...
Pharma Security World 2018 Anti-counterfeiting, Serialization & Brand Safety ...Pharma Security World 2018 Anti-counterfeiting, Serialization & Brand Safety ...
Pharma Security World 2018 Anti-counterfeiting, Serialization & Brand Safety ...Fazmina Fajju
 
Pharma compliance EU 2015
Pharma compliance EU 2015Pharma compliance EU 2015
Pharma compliance EU 2015Market iT
 
Anti Agenda 2017
Anti Agenda 2017Anti Agenda 2017
Anti Agenda 2017Mamta Gupta
 
Corporate Compliance & Transparency in the Pharmaceutical Industry
Corporate Compliance & Transparency in the Pharmaceutical IndustryCorporate Compliance & Transparency in the Pharmaceutical Industry
Corporate Compliance & Transparency in the Pharmaceutical IndustryMarket iT
 
SMi Group's 12th annual Parallel Trade 2018 conference
SMi Group's 12th annual Parallel Trade 2018 conferenceSMi Group's 12th annual Parallel Trade 2018 conference
SMi Group's 12th annual Parallel Trade 2018 conferenceDale Butler
 
Orphan Drugs Summit 2015
Orphan Drugs Summit 2015Orphan Drugs Summit 2015
Orphan Drugs Summit 2015Copperberg
 
CQ7126_IVD_Regulatory_and_Strategic_Forum_2015_Brochure
CQ7126_IVD_Regulatory_and_Strategic_Forum_2015_BrochureCQ7126_IVD_Regulatory_and_Strategic_Forum_2015_Brochure
CQ7126_IVD_Regulatory_and_Strategic_Forum_2015_BrochureKiran Bains
 
Clinical Trial Supply
Clinical Trial SupplyClinical Trial Supply
Clinical Trial SupplyAbdul Jamad
 
CQ5254 Pharmaceutical and Medical Device Labelling Summit
CQ5254 Pharmaceutical and Medical Device Labelling SummitCQ5254 Pharmaceutical and Medical Device Labelling Summit
CQ5254 Pharmaceutical and Medical Device Labelling SummitKiran Bains
 
London global transparency pc15105 brochure
London global transparency pc15105 brochureLondon global transparency pc15105 brochure
London global transparency pc15105 brochureMarket iT
 
(2286) World Orphan Drug Congress USA 2016 A4 32 Page Brochure 1.5 SCREEN SPREAD
(2286) World Orphan Drug Congress USA 2016 A4 32 Page Brochure 1.5 SCREEN SPREAD(2286) World Orphan Drug Congress USA 2016 A4 32 Page Brochure 1.5 SCREEN SPREAD
(2286) World Orphan Drug Congress USA 2016 A4 32 Page Brochure 1.5 SCREEN SPREADPinky Fadullon
 
SMi Group's 13th annual Parallel Trade 2019
SMi Group's  13th annual Parallel Trade 2019SMi Group's  13th annual Parallel Trade 2019
SMi Group's 13th annual Parallel Trade 2019Dale Butler
 
2nd European Conference on Clinical Research
2nd European Conference on Clinical Research2nd European Conference on Clinical Research
2nd European Conference on Clinical ResearchMarket iT
 
3rd corporate compliance & transparency in pharma
3rd corporate compliance & transparency in pharma3rd corporate compliance & transparency in pharma
3rd corporate compliance & transparency in pharmaMarket iT
 
Technology adoption in health – is the NHS ready? martin wakeley
Technology adoption in health – is the NHS ready? martin wakeleyTechnology adoption in health – is the NHS ready? martin wakeley
Technology adoption in health – is the NHS ready? martin wakeleySudeep Sakalle
 

Similar to Anti-Counterfeiting Pharma 2015 (20)

Pharma Security World 2018 Anti-counterfeiting, Serialization & Brand Safety ...
Pharma Security World 2018 Anti-counterfeiting, Serialization & Brand Safety ...Pharma Security World 2018 Anti-counterfeiting, Serialization & Brand Safety ...
Pharma Security World 2018 Anti-counterfeiting, Serialization & Brand Safety ...
 
Pharma compliance EU 2015
Pharma compliance EU 2015Pharma compliance EU 2015
Pharma compliance EU 2015
 
Anti Agenda 2017
Anti Agenda 2017Anti Agenda 2017
Anti Agenda 2017
 
Anti Agenda 2017
Anti Agenda 2017Anti Agenda 2017
Anti Agenda 2017
 
Anti Agenda 2017
Anti Agenda 2017Anti Agenda 2017
Anti Agenda 2017
 
Pv nov 2014
Pv nov 2014Pv nov 2014
Pv nov 2014
 
Corporate Compliance & Transparency in the Pharmaceutical Industry
Corporate Compliance & Transparency in the Pharmaceutical IndustryCorporate Compliance & Transparency in the Pharmaceutical Industry
Corporate Compliance & Transparency in the Pharmaceutical Industry
 
SMi Group's 12th annual Parallel Trade 2018 conference
SMi Group's 12th annual Parallel Trade 2018 conferenceSMi Group's 12th annual Parallel Trade 2018 conference
SMi Group's 12th annual Parallel Trade 2018 conference
 
Orphan Drugs Summit 2015
Orphan Drugs Summit 2015Orphan Drugs Summit 2015
Orphan Drugs Summit 2015
 
CQ7126_IVD_Regulatory_and_Strategic_Forum_2015_Brochure
CQ7126_IVD_Regulatory_and_Strategic_Forum_2015_BrochureCQ7126_IVD_Regulatory_and_Strategic_Forum_2015_Brochure
CQ7126_IVD_Regulatory_and_Strategic_Forum_2015_Brochure
 
PV 2016
PV 2016PV 2016
PV 2016
 
CTSC 16
CTSC 16CTSC 16
CTSC 16
 
Clinical Trial Supply
Clinical Trial SupplyClinical Trial Supply
Clinical Trial Supply
 
CQ5254 Pharmaceutical and Medical Device Labelling Summit
CQ5254 Pharmaceutical and Medical Device Labelling SummitCQ5254 Pharmaceutical and Medical Device Labelling Summit
CQ5254 Pharmaceutical and Medical Device Labelling Summit
 
London global transparency pc15105 brochure
London global transparency pc15105 brochureLondon global transparency pc15105 brochure
London global transparency pc15105 brochure
 
(2286) World Orphan Drug Congress USA 2016 A4 32 Page Brochure 1.5 SCREEN SPREAD
(2286) World Orphan Drug Congress USA 2016 A4 32 Page Brochure 1.5 SCREEN SPREAD(2286) World Orphan Drug Congress USA 2016 A4 32 Page Brochure 1.5 SCREEN SPREAD
(2286) World Orphan Drug Congress USA 2016 A4 32 Page Brochure 1.5 SCREEN SPREAD
 
SMi Group's 13th annual Parallel Trade 2019
SMi Group's  13th annual Parallel Trade 2019SMi Group's  13th annual Parallel Trade 2019
SMi Group's 13th annual Parallel Trade 2019
 
2nd European Conference on Clinical Research
2nd European Conference on Clinical Research2nd European Conference on Clinical Research
2nd European Conference on Clinical Research
 
3rd corporate compliance & transparency in pharma
3rd corporate compliance & transparency in pharma3rd corporate compliance & transparency in pharma
3rd corporate compliance & transparency in pharma
 
Technology adoption in health – is the NHS ready? martin wakeley
Technology adoption in health – is the NHS ready? martin wakeleyTechnology adoption in health – is the NHS ready? martin wakeley
Technology adoption in health – is the NHS ready? martin wakeley
 

Anti-Counterfeiting Pharma 2015

  • 1. Anti-Counterfeiting Pharma 2015 11th-12th March 2015 Marriott Regents Park, London, UK Roadmap and patient safety to brand protection Prominent Speakers:- üSophie Molle ,IPM Private Sector – Senior Manager, World Customs Organization üRoger Pallavicini, Sales Director Europe, Jura JSP GmbH üAndrew Love, VP Capability Development Be4ward Ltd üEdmond D'arvieu, Chief Security Officer, Sanofi üEric Noehrenberg, Regional Market Access and Policy Lead, Shire Pharmaceuticals üDammika Peiris, Pharmacovigilance Manager and Head of Chugai Pharma Marketing Pharmacovigilance Office, Chugai Pharma UK Ltd üSumit Munjal, Medical Director Lead, Global Medical Safety, Takeda Pharmaceuticals üAdesina Iluyemi, Executive Board member, NEPAD Council üMartin FitzGerald, Deputy Director General, GIRP üJanice Kite, Traceability Director Healthcare, GS1 Global Office üStephen Wilkins, Secretary, Child Safe Packaging Group üPaul Abbott, Associate, Arnold & Porter (UK) LLP üStephen Truick, Internet Infrastructure Manager, MHRA üMark Davison, CEO, Blue Sphere Health Ltd üStephen McIndoe, Vice President, Be4ward Ltd üJean-Luc Lasne, International Business Development & Alliance Director, Adents Pharma
  • 3. Floor Plan 13 14 15 16 12 11 10 9 1 2 Refreshment Station Conference Hall 4 3 Registration 6 7 8 RefreshmentStation 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 5
  • 4. Identify the current market trends in anti-counterfeiting, brand? protection and security packaging Gain Sanofi's perspective on key strategies for combating? anti-counterfeiting Overcome the main issues of online pharmaceutical crime? by learning from the presentation by MHRA. Understand the parallel trade, counterfeit products and? public health issues from Shire Pharmaceuticals. Hear thought provoking case study about preventing poisoning? through mobile technology by NEPAD Council. Discover latest solutions of future proofing a secure supply chain that will improve? your business model with The European Association of Pharmaceutical Full-line Wholesalers. Examine the recent EU&US anti-counterfeiting legislation with Arnold & Porter (UK)? LLP that will shape your future decisions. Learn how to enable regulatory compliance, supply chain security and patient safety? with GS1. Develop your serialisation strategy by learning from the experts from Blue Sphere? Health Ltd and Be4ward Ltd. Take part in the panel and roundtable discussions to interact, discuss and debate the? most crucial topics of anti-counterfeiting and brand protection in the industry. Why Attend?? Anti-Counterfeiting experts? R&D? Supply Chain and Track & Trace? Serialisation? Packaging Technologists? Regulatory Affairs, Intellectual Property and Trademarks? Innovation, Design and Development? Sales & Marketing? Brand Protection? Who will be attending?
  • 5. Day One: 11th March 2015 10:10 GS1 Standards: A tool for fighting counterfeiting? Ø ØThe latest in GS1 developments ØEnabling regulatory compliance, supply chain security and patient safety Daily interaction is natural and unnoticed Andrew Love, VP Capability Development, Be4ward Ltd 09:00 Chairman's opening remarks 09:10 Market trends: Anti-counterfeiting and Brand Protection ØMarket trends in anti-counterfeiting, brand protection and security packaging ØTrends in pharmaceutical packaging ØTechnologies and innovations ØOutlook for pharma security packaging Senior Representative, Smithers Pira ØLegal framework ØCounterfeit characteristics ØCounterfeit trends and opportunities: supply chain, diversion, parallel trade and product thefts ØAnti-counterfeit strategy: Two pillars 09:40 Key strategies for combating anti-counterfeiting - a pharma industry engagement Edmond D'arvieu, Chief Security Officer, Sanofi Janice Kite, Traceability Director Healthcare, GS1 Global Office 11:10 How to make your serialization project a success ? Mark Davison, CEO, Blue Sphere Health Ltd 11:30 Linking corporate strategy, brand protection and patient safety ØSerialisation and authentication as business critical initiatives ØProcess issues: what to look for ØAre you complying or competing? Achieving the elusive upside 08:30 Registration & refreshments 10:40 Coffee break & Speed Networking ØChoosing a relevant equipment ØPay attention to data exchange ØThe extra challenge of CMOs Jean-Luc Lasne, International Business Development & Alliance Director, Adents Pharma
  • 6. 14:20 Panel Discussion: Is the pharmaceutical industry doing enough to tackle counterfeit pharma products? ØChallenges in the industry ØSolutions that matter ØPublic and Private Sectors acting together against drug counterfeit Moderator: Andrew Love, VP Capability Development, Be4ward Ltd Panelists: ?Mark Davison, CEO, Blue Sphere Health Ltd ?Adesina Iluyemi, Executive Board member, NEPAD Council ?Edmond D'arvieu, Chief Security Officer, Sanofi ?Senior Representative, Aegate Roger Pallavicini, Sales Director Europe, Jura JSP GmbH 14:00 Add authentication to your identification system 12:20 Developing your Serialisation Strategy ØWhat are the capabilities that need to be implemented in a company to meet the needs of serialisation? ØHow do you ensure that the requirements for serialisation are thoroughly understood and capabilities effectively designed? ØHow do you ensure effective engagement across your extended supply chain? ØHow do you go about developing your serialisation strategy? Stephen McIndoe, Vice President Consulting, Be4ward Ltd 15:40 Panel Discussion: Is the pharmaceutical industry doing enough to tackle counterfeit pharma products? 12:50 Networking Lunch ØShare your views and provide an overview of your product/services to the audience 12:00 Sponsor Spotlight Session 15:20 Networking Coffee Ø ØSolutions that matter ØPublic and Private Sectors acting together against drug counterfeit Moderator: Andrew Love, VP Capability Development,Be4ward Ltd Panelists: • Stephen Wilkins, Secretary, Child Safe Packaging Group • Sumit Munjal,Medical Director Lead,Global Medical Safety ,Takeda Pharmaceuticals • Dammika Peiris ,Pharmacovigilance Manager and Head of Chug ai Pharma Marketing Pharmacovigilance Office, Chugai Pharma UK Ltd Challenges in the industry
  • 7. 17:10 Chairman's closing remarks 17:20 Networking drinks reception ØShare your views and provide an overview of your product/services to the audience 16:50 Sponsor Spotlight Session 16:20 Online Pharmaceutical Crime ØThe main issues - why is this still a problem ØThe current picture - it's not all Doom and Gloom ØThe future - when is a Door not a Door? Stephen Truick, Internet Infrastructure Manager, MHRA
  • 8. Day Two : 12th March 2015 Andrew Love, VP Capability Development, Be4ward Ltd 09:00 Chairman's opening remarks 09:10 Parallel trade and counterfeit products ØParallel trade, counterfeiting and public health ØThe extent of parallel trade and exploitation of parallel trade by drug counterfeiters ØImpact of EU Falsified Medicines Directive on parallel trade and counterfeiting ØImportance of cross-sectoral collaboration (including parallel traders) to fight counterfeiting Eric Noehrenberg, Regional Market Access and Policy Lead, Shire Pharmaceuticals ØDrug counterfeiting a public health problem in Africa ØAn international view of drug counterfeiting in Africa ØCases studies of how mobile technology us empowering consumers and regulators 10:00 Preventing poisoning- mobile technology to the rescue Adesina Iluyemi, Executive Board member, NEPAD Council Senior Representative, Yellow BP 10:30 Presentation to be announced Martin FitzGerald, Deputy Director General,The European Association of Pharmaceutical Full-line Wholesalers (GIRP) 11:20 Future proofing a secure supply chain ØAddressing the challenges of supply chain security through medicines verification systems ØStrategies for improving medicines supply ØInnovative partnerships between wholesalers and manufacturers in the area of services 08:30 Refreshments 10:50 Networking Coffee ØShare your views and provide an overview of your product/services to the audience 09:40 Sponsor Spotlight Session
  • 9. 15:50 Round table discussion Round table discussion with today's speakers and audience 14:00 EU & US anti-counterfeiting legislation ØBorder measures in the EU: the legislative framework ØThe international situation: where are we with ACTA / future regulation of IP enforcement globally? ØPractical measures for preventing import of counterfeit pharmaceuticals 16:30 Chair summary of the day and close of conference Paul Abbott, Associate, Arnold & Porter (UK) LLP 11:50 Presentation to be announced Stephen Wilkins, Secretary, Child Safe Packaging Group Sophie Molle, IPM Private Sector – Senior Manager, World Customs Organization 14:30 IPM- A WCO global initiative to fight against counterfeiting 12:40 Networking Lunch 15:20 Raising public awareness of the dangers of counterfeit medicines 15:00 Networking Coffee Share your views and provide an overview of your product/services to the audience 12:20 Sponsor Spotlight Session
  • 10. Delegate Pricing Information Book by 25 Dec2014 30 Jan 2015 30 Jan 2015 (Save upto ) (Save upto ) Standard Price 1 Delegate £550+ Vat £750+ Vat £950 + Vat 3 Delegates £1100+ Vat £1500 + Vat £1900+ Vat Book by Book after £800 £400 Commercial Opportunities:- Anti-Counterfeiting Pharma 2015 offers various opportunities for you to promote and showcase your organisation to the attendees. If you are interested in learning more about how we can work together please contact Sarika Sareen at sarika@recunnect.com Terms & Conditions: Payment Terms Recunnect Ltd. requires full payment of the amount to be made before the conference. We may refuse entry to a delegateor sponsor who have not paid in full. Cancellation or Substitution Policy Once registered, these places are not transferable without the agreement of Recunnect Ltd. for which reasonable priornotice must be given.For any cancellations received in writing not less than eight (8) days prior to the event, we will provide you with a 90%credit to be used at another Recunnect Ltd. event which must occur within one year from the date of issuance of suchcredit. An administration fee of 10% of the registration fee will be retained by Recunnect Ltd. for all permittedcancellations. No credit will be issued for any cancellations occurring within seven (7) days (inclusive) of the event. Indemnity Recunnect Ltd. reserves the right to make alterations to the event / executive briefing content, timing, speakers orprogram and venues. Where major or significant changes occur shortly before the conference date, Recunnect Ltd. willendeavor to take reasonable steps to notify the customers using the contact details supplied.The event may be postponed or cancelled due to unforeseen events beyond the control of Recunnect Ltd. In the eventthat Recunnect Ltd. cancels or postpones an event for any reason, the customer will receive a refund of the of theregistration fee paid. The refund will be made within 30 days from the date of cancellation of the conference. Fee The conference fee includes lunch, refreshments and conference papers provided on the day. This fee does not includetravel, hotel accommodation, transfers or insurance, (which we strongly recommend you obtain). Contact Our preferred method of communication is by email and phone. Please ensure that you complete the registration form infull so that we can contact you. By signing up for this conference you agree to abide by our terms and conditions. Please refer to our website for our fullterms and conditions. http://www.recunnect.com/terms-and-conditions.html RegistrationChecklist:- üHave you checked if any other colleagues are attending? üBooking early enough for maximum advantage? üAreyouavailingour3forthepriceof2offer? üUseyouraccountmanagercodetoavail £50discount. Ways to Book:- ü üCall +44 (0) 2071129183 üEmail: info@recunnect.com http://www.recunnect.com/p-anti-registration.html